Shenyang Xingqi Pharmaceutical Co.,Ltd

Shenzhen Stock Exchange 300573.SZ

Shenyang Xingqi Pharmaceutical Co.,Ltd Dividend Yield on January 14, 2025: 1.47%

Shenyang Xingqi Pharmaceutical Co.,Ltd Dividend Yield is 1.47% on January 14, 2025, a 67.39% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Shenyang Xingqi Pharmaceutical Co.,Ltd 52-week high Dividend Yield is 1.61% on January 09, 2025, which is 9.50% above the current Dividend Yield.
Shenyang Xingqi Pharmaceutical Co.,Ltd 52-week low Dividend Yield is 0.49% on May 14, 2024, which is -66.46% below the current Dividend Yield.
Shenyang Xingqi Pharmaceutical Co.,Ltd average Dividend Yield for the last 52 weeks is 1.02%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

Shenzhen Stock Exchange: 300573.SZ

Shenyang Xingqi Pharmaceutical Co.,Ltd

CEO	Ms. E. Gao
IPO Date	Dec. 9, 2016
Location	China
Headquarters	No. 68, Lishui Street
Employees	1,995
Sector	Health Care
Industries Pharmaceuticals Cosmetics Eyewear

Description

Shenyang Xingqi Pharmaceutical Co., Ltd engages in the research and development, production, and sale of ophthalmic products in China. It offers corneal, anti-bacteria, artificial tears, anti-inflammation, surgical perfusate, mydriactics, anti-fatigue, and pre dry and over dry eye treatment products. The company is based in Shenyang, China.

Key trends

Past 5 years